-
Signature
-
/s/ Tomas Kiselak, Managing Member of Fairmount Funds Management LLC
-
Stock symbol
-
SYRE
-
Transactions as of
-
Apr 25, 2024
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
4/25/2024, 04:55 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SYRE |
Common Stock |
Options Exercise |
$0 |
+3.64M |
+961.81% |
$0.00 |
4.02M |
Apr 25, 2024 |
By Fairmount Healthcare Fund II L.P. |
F1, F2 |
holding |
SYRE |
Common Stock |
|
|
|
|
|
406K |
Apr 25, 2024 |
By Tomas Kiselak |
|
holding |
SYRE |
Common Stock |
|
|
|
|
|
406K |
Apr 25, 2024 |
By Peter Harwin |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SYRE |
Series A Preferred Stock |
Options Exercise |
$0 |
-91K |
-20.82% |
$0.00 |
346K |
Apr 25, 2024 |
Common Stock |
3.64M |
|
By Fairmount Healthcare Fund II L.P. |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The Reporting Persons may each be deemed a director by deputization of Issuer by virtue of the fact that each of Peter Harwin and Tomas Kiselak serve on the board of directors of Issuer and are also each a Managing Member of Fairmount Funds Management LLC.